PUBLISHER: 360iResearch | PRODUCT CODE: 1380338
PUBLISHER: 360iResearch | PRODUCT CODE: 1380338
The Neuroprosthetics Market is projected to reach USD 29.83 billion by 2030 from USD 11.02 billion in 2022, at a CAGR of 13.25% during the forecast period.
Global Neuroprosthetics Market
KEY MARKET STATISTICS | |
---|---|
Base Year Value [2022] | USD 11.02 billion |
Estimated Year Value [2023] | USD 12.42 billion |
Forecast Year Value [2030] | USD 29.83 billion |
CAGR (%) | 13.25% |
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Neuroprosthetics Market.
Based on Product, market is studied across Input Neural Prosthetics and Output Neural Prosthetics. The Input Neural Prosthetics is further studied across Cochlear and Retinal. The Output Neural Prosthetics is further studied across Cognitive and Motor. The Output Neural Prosthetics is projected to witness significant market share during forecast period.
Based on Technique, market is studied across Deep Brain Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation, and Vagus Nerve Stimulation. The Deep Brain Stimulation is projected to witness significant market share during forecast period.
Based on Application, market is studied across Cognitive Disorders, Motor Neuron Disorders, and Physiological Disorders. The Cognitive Disorders is further studied across Alzheimer's Disease and Paralysis. The Motor Neuron Disorders is further studied across Epilepsy and Parkinson's Disease. The Physiological Disorders is further studied across Auditory Processing Disorders, Cardiovascular Disorders, Kidney Disorders, and Ophthalmic Disorders. The Motor Neuron Disorders is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is an indispensable tool for assessing the Neuroprosthetics Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
The Market Share Analysis offers invaluable insights into the vendor landscape Neuroprosthetics Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
The report delves into recent significant developments in the Neuroprosthetics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics, Axonics, Inc., Bioness Inc., Boston Scientific Corporation, BrainsWay, Ltd., CorTec GmbH, eNeura Inc., LivaNova PLC, MED-EL Elektromedizinische Gerate Gesellschaft m.b.H., Medtronic PLC, MicroTransponder Inc., NDI, NERVANA LLC, Neuronetics, Inc., NeuroPace, Inc., Nevro Corporation, Nexstim Oyj, Ottobock SE & Co. KGaA, Renishaw PLC, SceneRay Co., Ltd., SetPoint Medical Corporation, Synchron, and Zimmer Biomet.
1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast for the Neuroprosthetics Market?
2. Which products, segments, applications, and areas hold the highest investment potential in the Neuroprosthetics Market?
3. What is the competitive strategic window for identifying opportunities in the Neuroprosthetics Market?
4. What are the latest technology trends and regulatory frameworks in the Neuroprosthetics Market?
5. What is the market share of the leading vendors in the Neuroprosthetics Market?
6. Which modes and strategic moves are suitable for entering the Neuroprosthetics Market?